← All stocks

CVS Health

CVS Net selling
CIK 0000064803 #141 in the set updated 17 Sep 2026
Bought (120 mo)
$8.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$928.33M
$0.00 on a plan · $327.10M straight out of an exercise
Sold at will
$601.23M
33 of 114 sales
Net
−$919.87M
−$592.77M against sales at will

By person

56 insiders · 138 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ROBBINS LARRY
Director
$571.17M (13)
−$571.17M
4,824,799
$450.87M
−59.6%
MERLO LARRY J
Director
$93.24M (7) scheduled
−$93.24M
632,313
$59.09M
+42.6%
Moriarty Thomas M
EVP & General Counsel
$66.76M (14) scheduled
−$66.76M
333,499
$31.16M
Denton David M
EVP and CFO
$47.05M (6) scheduled
−$47.05M
403
$37.66K
−99.8%
Roberts Jonathan C
EVP & Chief Operating Officer
$44.39M (7) scheduled
−$44.39M
426,025
$39.81M
Brennan Troyen A
EVP and Chief Medical Officer
$30.99M (12) scheduled
−$30.99M
232,676
$21.74M
+119.1%
Lotvin Alan
EVP&President-PharmacyServices
$315.68K (1)
$19.14M (7) scheduled
−$18.82M
109,183
$10.20M
Finke Daniel P
EVP/Pres, Health Care Benefits
$10.35M (6) scheduled
−$10.35M
35,068
$3.28M
−20.1%
Foulkes Helena
EVP & President-CVS Pharmacy
$7.83M (4) scheduled
−$7.83M
45,107
$4.22M
+253.2%
Mandadi Tilak
EVP, Chief Exp & Tech Officer
$6.23M (1)
−$6.23M
10,133
$946.91K
Bisaccia Lisa
Former EVP & Chief HR Officer
$5.87M (4) scheduled
−$5.87M
66,417
$6.21M
+100.5%
Shah Prem S
EVP and Group President
$5.10M (9) scheduled
−$5.10M
64,356
$6.01M
Lynch Karen S
President and CEO
$976.57K (1)
$6.01M (1)
−$5.03M
506,079
$47.29M
Clark James David
SVP, Cont & Chief Acct Officer
$4.20M (9)
−$4.20M
27,606
$2.58M
+3,076%
Boratto Eva C
EVP & CFO
$4.19M (6) scheduled
−$4.19M
115,331
$10.78M
+125.9%
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL
$2.62M (2) scheduled
−$2.62M
25,657
$2.40M
+5.3%
Mahoney Michael F
Director
$2.50M (2)
+$2.50M
45,701
$4.27M
+26,015%
DORMAN DAVID W
Director
$2.02M (2)
+$2.02M
109,875
$10.27M
+247.8%
BROWN C DAVID II
Director
$1.15M (2)
+$1.15M
129,316
$12.08M
+41.7%
Sussman Andrew
EVP, Clinical Services
$1.13M (2) scheduled
−$1.13M
16,433
$1.54M
+1.0%
LUDWIG EDWARD J
Director
$1.09M (7)
+$1.09M
21,630
$2.02M
Mayhew Jonathan E.
EVP - Transformation
$686.14K (1)
−$686.14K
6,855
$640.59K
−64.1%
Hourican Kevin
EVP & President, CVS Pharmacy
$642.30K (1) scheduled
−$642.30K
15,237
$1.42M
−1.7%
Finucane Anne A.
Director
$532.65K (1)
−$532.65K
22,747
$2.13M
+20.0%
AGUIRRE FERNANDO
Director
$300.59K (2)
+$300.59K
10,513
$982.42K
SWIFT RICHARD J
Director
$199.05K (1)
−$199.05K
7,336
$685.54K
+46.1%
SANSONE GUY P
Director
$100.01K (1)
+$100.01K
15,106
$1.41M
+145.2%
CAPOZZI HEIDI B
EVP and Chief People Officer
$4.59K (3)
+$4.59K
13,108
$1.22M
Nelson Steven H
EVP and President, Aetna
$1.29K (1)
+$1.29K
2,924
$273.24K
PELUSO MICHELLE A
EVP and Co-President of Retail
124,383
$11.62M
+126.0%
Kraft Robert O.
EVP and President - Omnicare
92,360
$8.63M
+8.5%
Joyner J. David
President, CEO and Chair
70,349
$6.57M
GOLD STEPHEN J
EVP & CIO
46,818
$4.38M
+38.8%
COWHEY THOMAS F.
EVP and CFO
41,109
$3.84M
+123.8%
WHITE TONY L
Director
37,852
$3.54M
+85.1%
GUERTIN SHAWN M
EVP & Chief Financial Officer
34,706
$3.24M
DEPARLE NANCY ANN
Director
34,169
$3.19M
+487.6%
Khichi Samrat S.
EVP, CPO and General Counsel
33,421
$3.12M
Montgomery Neela
EVP and Pres., Pharmacy/Retail
29,502
$2.76M
Rice Derica W
EVP & President, CVS Caremark
26,827
$2.51M
+62.2%
Chaguturu Sreekanth K
EVP and Chief Medical Officer
23,666
$2.21M
FARAH ROGER N
Director
19,438
$1.82M
Balser Jeffrey R.
Director
15,717
$1.47M
+7,110%
BRACKEN RICHARD M
Director
15,348
$1.43M
+290.8%
KIRBY J SCOTT
Director
14,434
$1.35M
Bertolini Mark T
Director
13,773
$1.29M
Kane Brian A
EVP/President, Aetna
12,569
$1.17M
Compton-Phillips Amy
EVP, Chief Medical Officer
9,557
$893.08K
Havanec Laurie P.
EVP and Chief People Officer
9,426
$880.84K
SCHAPIRO MARY L
Director
7,585
$708.80K
Norwalk Leslie V
Director
7,376
$689.27K
Shulman Douglas H.
Director
5,929
$554.05K
MILLON JEAN PIERRE
Director
4,514
$421.83K
Newman Brian
EVP, Chief Financial Officer
3,008
$281.09K
DECOUDREAUX ALECIA A
Director
2,970
$277.54K
Gallina John E
Director
582
$54.39K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 595
Amendments (4/A) skipped 18
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 81
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 14,477,869
Sales filed before the plan box existed 15
History held since 4 Nov 2016